RECENT evidence suggests that the growth associated protein GAP-43 is
involved in the pathology of amyotrophic lateral sclerosis (ALS). In o
rder to assess the primary structure of the GAP-43 mRNA expressed in t
he spinal cord of ALS patients, the total coding region of the GAP-43
mRNA was amplified from postmortem human spinal cord specimens using t
he reverse transcriptase-polymerase chain reaction (RT-PCR) method. GA
P-43 amplification products were clearly detected in all of the ALS ca
ses but not in the normal controls. The GAP-43 mRNA and the deduced am
ino acid sequences from all ALS cases coincided completely with the se
quence of human fetal GAP-43. These results suggest that the abnormal
expression of GAP-43 mRNA underlying the pathogenesis of ALS is due to
a quantitative increase, and that there are no qualitative abnormalit
ies associated with a change in the amino acid sequences. (C) 1998 Rap
id Science Ltd.